A new approach for improving diagnostic accuracy in Alzheimer's disease and frontal lobe dementia utilising the intrinsic properties of the SPET dataset

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 30, Issue 11, 2003, Pages 1481-1488

  Pagani, Marco ^a,e   Kovalev, Vassili A ^b,c   Lundqvist, Roger ^d   Jacobsson, Hans ^a   Larsson, Stig A ^a   Thurfjell, Lennart ^d  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNITED INSTITUTE OF INFORMATICS PROBLEMS   (Belarus)

^c MAX PLANCK INSTITUTE FOR HUMAN COGNITIVE AND BRAIN SCIENCES   (Germany)

^d Applied Medical Imaging   (Sweden)

^e INSTITUTE OF COGNITIVE SCIENCES AND TECHNOLOGIES   (Italy)

Author keywords

Accuracy; Alzheimer's disease; Co occurrence matrices; Features; SPET

Indexed keywords

HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M;

AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN BLOOD FLOW; CLINICAL ARTICLE; DEMENTIA; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE CLASSIFICATION; FEMALE; FRONTAL LOBE; HISTOGRAM; HUMAN; IMAGE PROCESSING; MALE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

AGED; AGED, 80 AND OVER; ALGORITHMS; ALZHEIMER DISEASE; DATABASES, FACTUAL; DEMENTIA; DIAGNOSIS, DIFFERENTIAL; EXPERT SYSTEMS; FEMALE; FRONTAL LOBE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MALE; MIDDLE AGED; PATTERN RECOGNITION, AUTOMATED; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 0242365479     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-003-1196-z     Document Type: Article

References (48)

1. Wallin A, Brun A, Gustafson L and the Swedish Consensus Group. Swedish Consensus on dementia disease. Acta Neurol Scand 1994; 90 (Suppl):S1-S31.
2. 99mTc-HM-PAO in the investigation of dementia. J Neurol Neurosurg Psychiatry 1987; 50:1101-1109.
3. m-HM-PAO for the diagnosis of dementia. Nucl Med Commun 1987; 8:525-533.
4. 99mTc-HMPAO in patients with presenile Alzheimer's disease and Korsakoff's psychosis. Psychol Med 1989; 19:847-855.
5. Jagust WJ, Eberling JL, Reed BR, Mathis CA, Budinger TF. Clinical studies of cerebral blood flow in Alzheimer's disease. Ann N Y Acad Sci 1997; 826:254-262.
6. Neary D, Snowden JS, Gustafson L, et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology 1998; 51:1546-1554.
7. Jagust WJ, Reed BR, Seab JP, Kramer JH, Budinger TF. Clinical-physiologic correlates of Alzheimer's disease and frontal lobe dementia. Am J Physiol Imaging 1989; 4:89-96.
8. Julin P, Wahlund LO, Basun H, Persson A, Måre K, Rudberg U. Clinical diagnosis of frontal lobe dementia and Alzheimer's disease: relation to cerebral perfusion, brain atrophy and electroencephalography. Dement Geriatr Cogn Disord 1995; 6:142-147.
9. Risberg J, Gustafson L. Regional cerebral blood flow measurements in the clinical evaluation of demented patients. Dement Geriatr Cogn Disord 1997; 8:92-97.
10. Holman BL, Johnson KA, Gerada B, Carvalho PA, Satlin A. The scintigraphic appearance of Alzheimer's disease: a prospective study using technetium-99m-HMPAO SPECT. J Nucl Med 1992; 33:181-185.
11. 99mTc]-d,l-HMPAO SPECT study. J Neurol Neurosurg Psychiatry 1994; 57:285-295.
12. 123I]-IBZM in Alzheimer's disease and dementia of frontal type: preliminary results. Acta Neurol Scand 1994; 89:199-203.
13. Ryding E. SPECT measurements of brain function in dementia; a review. Acta Neurol Scand 1996; 168 (Suppl):S54-S58.
14. Syed GMS, Eagger S, O'Brien J, Barrett JJ, Levy R. Patterns of regional cerebral blood flow in Alzheimer's disease. Nucl Med Commun 1992; 13:656-663.
15. O'Mahony, Coffey J, Murphy J, et al. The discriminant value of semiquantitative SPECT data in mild Alzheimer's disease. J Nucl Med 1994; 35:1450-1455.
16. Houston AS, Kemp PM, Macleod MA, Francis JR, Colohan HA, Matthews HP. Use of significance image to determine patterns of cortical blood flow abnormality in pathological and at-risk groups. J Nucl Med 1998; 39:425-430.
17. Hamilton D, O'Mahony D, Coffey J, Murphy J, O'Hare N, Freyne P, Walsh B, Coakley D. Classification of mild Alzheimer's disease by artificial neural network analysis of SPET data. Nucl Med Commun 1997; 18:805-810.
18. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12:189-198.
19. 99mTc-HMPAO SPET in healthy subjects at rest: normal distribution and effect of age and gender. Eur J Nuc Med 2002; 29:67-75.
20. Chang L-T. A method for attenuation correction in radionuclide computed tomography. IEEE Trans Nucl Sci 1978; 25:638-643.
21. Greitz T, Bohm C, Holte S, Eriksson L. A computerized brain atlas: construction, anatomical content, and some applications. J Comput Assist Tomogr 1991; 15:26-38.
22. Thurfjell L, Bohm C, Bengtsson E. CBA - an atlas based software tool used to facilitate the interpretation of neuroimaging data. Comput Methods Programs Biomed 1995; 4:51-71.
23. Andersson JLR, Thurfjell L. Implementation and validation of a fully automatic system for intra- and inter-individual registration of PET brain scans. J Comput Assist Tomogr 1997; 21:136-144.
24. Thurfjell L, Bohm C, Greitz T, Eriksson L. Transformations and algorithms in a computerized brain atlas. IEEE Trans Nucl Sci 1993; 40:1187-1191.
25. Gonzales RC, Woods RE. Digital image processing. Reading: Addison-Wesley; 1992:508-510.
26. Kovalev VA, Kruggel F, Gertz H-J, von Cramon DY. Three dimensional texture analysis of MRI brain datasets. IEEE Trans Med Imaging 2001; 20:424-433.
27. Zucker SW, Hummel RA. A 3D edge operator. IEEE Trans PAMI 1981; 3:324-331.
28. Kovalev V, Thurfjell L, Lundqvist R, Pagani M. Classification of SPECT scans of Alzheimer's disease and frontal lobe dementia based on intensity and gradient information. In: Medical image understanding and analysis. MIUA'99. Oxford, 19-20 July. 1999:69-72.
29. Seber GAF. Multivariate analysis. New York: Wiley, 1984.
30. 99mTc-HMPAO uptake in Alzheimer's disease and frontal lobe dementia with SPECT. Dement Geriatr Cogn Disord 2001; 12:177-184.
31. Starkstein SE, Migliorelli R, Teson A, Sabe L, Vazquez S, Turjanski M, Robinson RG, Leiguarda R. Specificity of changes in cerebral blood flow in patients with frontal lobe dementia. J Neurol Neurosurg Psychiatry 1994; 57:790-796.
32. Minoshima S, Frey K, Koeppe R, Foster N, Kuhl D. A diagnostic approach in Alzheimer's disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET. J Nucl Med 1995; 36:1238-1248.
33. Birtenstein P, Minoshima S, Hirsch C, et al. Quantitative assessment of cerebral blood flow in patients with Alzheimer's disease by SPECT. J Nucl Med 1997; 38:1095-1101.
34. 99mTc HMPAO SPET: developing diagnostics in Alzheimer's disease. Eur J Nucl Med Mol Imaging 2002; 29:1140-1148.
35. Varrone A, Pappata S, Caraco C, Soricelli A, Milan G, Quarantelli M, Alfano B, Postiglione A, Salvatore M. Voxel-based comparison of rCBF SPET images in frontotemporal dementia and Alzheimer's disease highlights the involvement of different cortical networks. Eur J Nucl Med Mol Imaging 2002; 29:1447-1454.
36. Borght T, Minoshima S, Giordani B, et al. Cerebral metabolic differences in Parkinson's and Alzheimer's disease matched for dementia severity. J Nucl Med 1997; 38:797-801.
37. Imran MB, Kawashima R, Awata S, et al. Parametric mapping of cerebral blood flow deficits in Alzheimer's disease: a SPECT study using HMPAO and image standardization technique. J Nucl Med 1999; 40:244-249.
38. 99mTc-ECD brain perfusion SPET: variability, asymmetry and effect of age and gender in healthy adults. Eur J Nucl Med 2001; 28:873-887.
39. Van Gool WA, Walstra GJ, Teunisse S, Van der Zant FM, Weinstein HC, Van Royen EA. Diagnosing Alzheimer's disease in elderly, mildly demented patients: the impact of routine single photon emission computed tomography. J Neurol 1995; 242:401-405.
40. Read SL, Miller BL, Mena I, Kim R, Itabashi H, Darby A. SPECT in dementia: clinical and pathological correlation. J Am Geriatr Soc 1995; 43:1243-1247.
41. van Dyck CH, Lin CH, Smith EO, Wisniewski G, Cellar J, Robinson R, Narayan M, Bennett A, Delaney RC, Bronen RA, Hoffer PB. Comparison of technetium-99m-HMPAO and technetium-99m-ECD cerebral SPECT images in Alzheimer's disease. J Nucl Med 1996; 37:1749-1755.
42. Masterman DL, Mendez MF, Fairbanks LA, Cummings JL. Sensitivity, specificity, and positive predictive value of technetium 99-HMPAO SPECT in discriminating Alzheimer's disease from other dementias. J Geriatr Psychiatry Neurol 1997; 10:15-21.
43. Bonte FJ, Weiner MF, Bigio EH, White CL 3rd. Brain blood flow in the dementias: SPECT with histopathologic correlation in 54 patients. Radiology 1997; 202:793-797.
44. Jobst KA, Barnetson LP, Shepstone BJ. Accurate prediction of histologically confirmed Alzheimer's disease and the differential diagnosis of dementia: the use of NINCDS-ADRDA and DSM-III-R criteria, SPECT, X-ray CT, and Apo E4 in medial temporal lobe dementias. Oxford Project to Investigate Memory and Aging. Int Psychogeriatr 1998; 10:271-302.
45. Obrien JT, Ames D, Desmond P, Lichtenstein M, Binns D, Schweitzer I, Davis S, Tress B. Combined magnetic resonance imaging and single-photon emission tomography scanning in the discrimination of Alzheimer's disease from age-matched controls. Int Psychogeriatr 2001; 13:149-161.
46. Varma AR, Adams W, Lloyd JJ, Carson KJ, Snowden JS, Testa HJ, Jackson A, Neary D. Diagnostic patterns of regional atrophy on MRI and regional cerebral blood flow change on SPECT in young onset patients with Alzheimer's disease, frontotemporal dementia and vascular dementia. Acta Neurol Scand 2002; 105:261-269.
47. Jagust W, Thisted R, Devous MD Sr, Van Heertum R, Mayberg H, Jobst K, Smith AD, Borys N. SPECT perfusion imaging in the diagnosis of Alzheimer's disease: a clinical-pathologic study. Neurology 2001; 56:950-956.
48. Silverman DH, Gambhir SS, Huang HW, Schwimmer J, Kim S, Small GW, Chodosh J, Czernin J, Phelps ME. Evaluating early dementia with and without assessment of regional cerebral metabolism by PET: a comparison of predicted costs and benefits. J Nucl Med 2002; 43:253-266.